Biocompatibility & Safety Testing of
Medical Devices
Where Science Safeguards Innovation
At AAL Biosciences, we help Medical Device innovators establish biological safety with precision and confidence.
Our comprehensive Biocompatibility & Safety Testing services, conducted in accordance with the ISO 10993 series, evaluate how devices and materials interact with the human body, ensuring patient safety, product reliability, and regulatory compliance.
With GLP-compliant infrastructure, advanced facilities, and a team of ABT-certified toxicologists, AAL Bio delivers dependable data for global submissions, including FDA, EU MDR, and CDSCO. At our lab, we conduct an extensive range of biocompatibility evaluations that determine systemic, local, and cellular responses to medical devices and materials.
Necessity of Biocompatibility & Safety Testing
Here is why biocompatibility & safety testing are pivotal in medical device testing:
Ensures Patient Safety
Confirms that medical devices are non-toxic, non-irritant, and safe for intended contact with the body.
Supports Regulatory Approvals:
Provides the scientific evidence required to comply with ISO 10993, USP, FDA, and EU MDR standards.
Validates Material Selection
Helps identify safe and biocompatible materials early in the design phase, reducing costly redesigns
Predicts Long-Term Biological Responses
Evaluates chronic and systemic effects to ensure performance and safety throughout the product lifecycle.
Builds Market Confidence
Demonstrates a proven commitment to quality, ethics, and patient well-being, strengthening brand credibility.
Areas of Expertise
Alternatives to Animal Models
- In-Vitro Skin Irritation & Corrosion
- Hen’s Egg Test – Chorioallantoic Membrane (HET-CAM)
- In-Vitro Skin/Dermal Absorption Using Ex-Vivo Models
Microbiological Safety Testing
- Sterility Testing
- Bioburden Testing
- Bacterial Endotoxin Testing
In-Vitro & In-Vivo Genotoxicity Testing (ISO 10993-5)
- Bacterial Reverse Mutation Test (Ames Test)
- In-Vitro Mammalian Chromosome Aberration Test
- In-Vitro Micronucleus Test
- In-Vivo Mammalian Erythrocyte Micronucleus Test
- In-Vivo Mammalian Bone Marrow Chromosome Aberration Test
In-Vitro Cytotoxicity Testing (ISO 10993-5)
- Agarose Overlay
- MEM Elution
- Direct Contact
- Quantitative MTT Assay
USP Plastics (USP Class I–VI)
- Systemic Injection Test
- Intracutaneous Test
- Implant Test
- Safety Evaluation
Pyrogenicity Testing
- Material Mediated Pyrogenicity (ISO 10993-11)
- Rabbit Pyrogen Test (IP, BP, and USP)
Hemocompatibility Testing (ISO 10993-4)
- ASTM Hemolysis
- Complement Assay (C3a and SC5b-9)
- Partial Thromboplastin Time (PTT)
- Prothrombin Time (PT)
- Thrombin Time (TT)
Implantation Testing (ISO 10993-6 & USP)
- Intramuscular Implantation
- Subcutaneous Implantation
- Bone Implantation
- Ocular Implantation
- Mucosal Irritation (vaginal, rectal, oral)
Irritation & Sensitisation (ISO 10993-10 & USP)
- Intracutaneous Reactivity
- Dermal and Mucosal Irritation (vaginal, rectal, oral)
- Ocular and Intraocular Irritation
- Closed Patch (Buehler) Dermal Irritation
- Guinea Pig Maximisation Test
- Local Lymph Node Assay (LLNA) by BrdU ELISA
Systemic Toxicity (ISO 10993-11)
- Acute Systemic Toxicity
- Sub-Acute Toxicity
- Sub-Chronic Toxicity
- Chronic Systemic Toxicity
- Reproductive Toxicity